10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

FYB (Formycon) Stock Analysis
Buy, Hold or Sell?

Let's analyze Formycon together

I guess you are interested in Formycon AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Formycon’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Formycon’s Price Targets

I'm going to help you getting a better view of Formycon AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Formycon AG

I send you an email if I find something interesting about Formycon AG.

1. Quick Overview

1.1. Quick analysis of Formycon (30 sec.)










1.2. What can you expect buying and holding a share of Formycon? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€26.15
Expected worth in 1 year
€16.88
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
€-9.26
Return On Investment
-31.8%

For what price can you sell your share?

Current Price per Share
€29.10
Expected price per share
€21.75 - €37.65
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Formycon (5 min.)




Live pricePrice per Share (EOD)
€29.10
Intrinsic Value Per Share
€-44.97 - €-20.64
Total Value Per Share
€-18.82 - €5.51

2.2. Growth of Formycon (5 min.)




Is Formycon growing?

Current yearPrevious yearGrowGrow %
How rich?$544m$592.1m-$48.1m-8.9%

How much money is Formycon making?

Current yearPrevious yearGrowGrow %
Making money-$148m$89.2m-$237.3m-160.3%
Net Profit Margin-180.4%97.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Formycon (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#116 / 881

Most Revenue
#107 / 881

Most Profit
#865 / 881

Most Efficient
#566 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Formycon?

Welcome investor! Formycon's management wants to use your money to grow the business. In return you get a share of Formycon.

First you should know what it really means to hold a share of Formycon. And how you can make/lose money.

Speculation

The Price per Share of Formycon is €29.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Formycon.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Formycon, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €26.15. Based on the TTM, the Book Value Change Per Share is €-2.32 per quarter. Based on the YOY, the Book Value Change Per Share is €8.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Formycon.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps-8.38-28.8%-8.38-28.8%5.0517.4%-0.31-1.1%-0.44-1.5%-0.22-0.8%
Usd Book Value Change Per Share-2.73-9.4%-2.73-9.4%9.7533.5%9.0231.0%5.5219.0%2.9910.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-2.73-9.4%-2.73-9.4%9.7533.5%9.0231.0%5.5219.0%2.9910.3%
Usd Price Per Share62.55-62.55-66.43-76.96-72.56-52.56-
Price to Earnings Ratio-7.46--7.46-13.14-16.04--37.44--11.03-
Price-to-Total Gains Ratio-22.93--22.93-6.82--3.68--9.93-10.32-
Price to Book Ratio2.03-2.03-1.98-2.77-8.14-12.59-
Price-to-Total Gains Ratio-22.93--22.93-6.82--3.68--9.93-10.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share34.27689
Number of shares29
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-2.735.52
Usd Total Gains Per Share-2.735.52
Gains per Quarter (29 shares)-79.11159.97
Gains per Year (29 shares)-316.43639.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-316-3260640630
20-633-642012801270
30-949-958019201910
40-1266-1274025602550
50-1582-1590031993190
60-1899-1906038393830
70-2215-2222044794470
80-2531-2538051195110
90-2848-2854057595750
100-3164-3170063996390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%5.011.00.031.3%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%12.04.00.075.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.016.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%12.04.00.075.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Formycon AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.316-2.3160%8.275-128%7.660-130%4.683-149%2.537-191%
Book Value Per Share--26.14526.1450%28.461-8%24.931+5%16.362+60%9.046+189%
Current Ratio--2.8042.8040%0.969+189%1.458+92%3.616-22%6.611-58%
Debt To Asset Ratio--0.4020.4020%0.435-8%0.473-15%0.346+16%0.242+66%
Debt To Equity Ratio--0.6710.6710%0.771-13%0.945-29%0.642+4%0.402+67%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--669947640.000669947640.0000%635702160.000+5%782107800.000-14%873954904.200-23%687269885.300-3%
Eps---7.114-7.1140%4.291-266%-0.262-96%-0.377-95%-0.190-97%
Ev To Ebitda Ratio---163.442-163.4420%7.843-2184%-45.135-72%-76.934-53%-139.049-15%
Ev To Sales Ratio--9.6159.6150%8.182+18%14.095-32%19.880-52%19.596-51%
Free Cash Flow Per Share---3.009-3.0090%-1.732-42%-2.444-19%-1.697-44%-0.856-72%
Free Cash Flow To Equity Per Share---0.775-0.7750%0.784-199%-0.089-88%0.013-5967%0.199-490%
Gross Profit Margin--1.0101.0100%0.989+2%0.986+2%1.025-1%1.0120%
Intrinsic Value_10Y_max---20.640----------
Intrinsic Value_10Y_min---44.966----------
Intrinsic Value_1Y_max---1.120----------
Intrinsic Value_1Y_min---2.994----------
Intrinsic Value_3Y_max---4.087----------
Intrinsic Value_3Y_min---10.359----------
Intrinsic Value_5Y_max---7.926----------
Intrinsic Value_5Y_min---19.161----------
Market Cap514034040.000-82%937979640.000937979640.0000%996272160.000-6%1154074133.333-19%1088127040.000-14%788273850.000+19%
Net Profit Margin---1.804-1.8040%0.976-285%0.006-28961%-0.103-94%-0.065-96%
Operating Margin---2.055-2.0550%1.019-302%0.044-4736%-0.090-96%-0.057-97%
Operating Ratio--1.3381.3380%1.005+33%1.253+7%1.261+6%1.144+17%
Pb Ratio1.113-82%2.0312.0310%1.982+2%2.766-27%8.141-75%12.590-84%
Pe Ratio-4.090+45%-7.464-7.4640%13.144-157%16.045-147%-37.439+402%-11.032+48%
Price Per Share29.100-82%53.10053.1000%56.400-6%65.333-19%61.600-14%44.625+19%
Price To Free Cash Flow Ratio-9.669+45%-17.644-17.6440%-32.561+85%-27.867+58%-63.077+257%-343.925+1849%
Price To Total Gains Ratio-12.566+45%-22.929-22.9290%6.816-436%-3.677-84%-9.925-57%10.317-322%
Quick Ratio--2.1412.1410%0.799+168%2.229-4%3.740-43%8.859-76%
Return On Assets---0.163-0.1630%0.085-291%-0.012-93%-0.060-63%-0.036-78%
Return On Equity---0.272-0.2720%0.151-280%-0.007-97%-0.069-75%-0.041-85%
Total Gains Per Share---2.316-2.3160%8.275-128%7.660-130%4.683-149%2.537-191%
Usd Book Value--544004869.700544004869.7000%592190402.900-8%518736951.533+5%340436661.534+60%188211517.135+189%
Usd Book Value Change Per Share---2.728-2.7280%9.747-128%9.023-130%5.516-149%2.989-191%
Usd Book Value Per Share--30.79730.7970%33.525-8%29.366+5%19.272+60%10.655+189%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--789131325.156789131325.1560%748793574.264+5%921244777.620-14%1029431481.657-23%809535197.895-3%
Usd Eps---8.380-8.3800%5.054-266%-0.309-96%-0.444-95%-0.224-97%
Usd Free Cash Flow---62618341.900-62618341.9000%-36040206.300-42%-50850335.633-19%-35301898.580-44%-17802980.607-72%
Usd Free Cash Flow Per Share---3.545-3.5450%-2.040-42%-2.879-19%-1.998-44%-1.008-72%
Usd Free Cash Flow To Equity Per Share---0.912-0.9120%0.923-199%-0.105-88%0.016-5967%0.234-490%
Usd Market Cap605480695.716-82%1104846217.9561104846217.9560%1173508977.264-6%1359383921.653-19%1281704840.416-14%928507767.915+19%
Usd Price Per Share34.277-82%62.54662.5460%66.434-6%76.956-19%72.559-14%52.564+19%
Usd Profit---148029048.800-148029048.8000%89278930.500-266%-5451713.833-96%-7797864.084-95%-3930106.932-97%
Usd Revenue--82069004.60082069004.6000%91518118.400-10%74548113.100+10%61417340.690+34%47389172.561+73%
Usd Total Gains Per Share---2.728-2.7280%9.747-128%9.023-130%5.516-149%2.989-191%
 EOD+3 -5MRQTTM+0 -0YOY+10 -283Y+11 -275Y+6 -3210Y+8 -30

3.3 Fundamental Score

Let's check the fundamental score of Formycon AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.090
Price to Book Ratio (EOD)Between0-11.113
Net Profit Margin (MRQ)Greater than0-1.804
Operating Margin (MRQ)Greater than0-2.055
Quick Ratio (MRQ)Greater than12.141
Current Ratio (MRQ)Greater than12.804
Debt to Asset Ratio (MRQ)Less than10.402
Debt to Equity Ratio (MRQ)Less than10.671
Return on Equity (MRQ)Greater than0.15-0.272
Return on Assets (MRQ)Greater than0.05-0.163
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Formycon AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.538
Ma 20Greater thanMa 5027.815
Ma 50Greater thanMa 10025.261
Ma 100Greater thanMa 20026.105
OpenGreater thanClose28.950
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Formycon AG

Formycon AG, a biotechnology company, develops biosimilar drugs in Germany and Switzerland. It provides ranibizumab and aflibercept used in the treatment of neovascular age-related macular degeneration, diabetic macular edema, choroidal neovascularization, proliferative diabetic retinopathy, and macular edema under the Ranivisio, Ongavia, Cimerli, Ranopto, Uptera, and Ravegza brand names, as well as AHZANTIVE, Baiama, and Fovlya brand names. The company's pipeline includes ustekinumab used in the treatment of Crohn's disease, ulcerative colitis, Plaque Psoriasis, and Psoriatic Arthritis under the Otulf, Fymskina, and Sitovab brand names. It is also developing pembrolizumab for the treatment of immuno-oncology diseases, such as advanced melanoma, non-small cell bronchial carcinoma, hodgkin's lymphoma, urothelial carcinomas, tumors in the head and neck area, other tumor diseases; and FYB208 and FYB209 that is indicated for immunology areas. The company was formerly known as Nanohale AG and changed its name to Formycon AG in 2012. Formycon AG was founded in 1999 and is headquartered in Planegg, Germany.

Fundamental data was last updated by Penke on 2025-06-18 04:28:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Formycon earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Formycon to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -180.4%Β means thatΒ €-1.80 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Formycon AG:

  • The MRQ is -180.4%. The company is making a huge loss. -2
  • The TTM is -180.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-180.4%TTM-180.4%0.0%
TTM-180.4%YOY97.6%-277.9%
TTM-180.4%5Y-10.3%-170.0%
5Y-10.3%10Y-6.5%-3.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-180.4%-91.7%-88.7%
TTM-180.4%-139.0%-41.4%
YOY97.6%-194.4%+292.0%
3Y0.6%-248.5%+249.1%
5Y-10.3%-343.3%+333.0%
10Y-6.5%-488.9%+482.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Formycon is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Formycon to theΒ Biotechnology industry mean.
  • -16.3% Return on Assets means thatΒ Formycon generatedΒ €-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Formycon AG:

  • The MRQ is -16.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-16.3%0.0%
TTM-16.3%YOY8.5%-24.8%
TTM-16.3%5Y-6.0%-10.2%
5Y-6.0%10Y-3.6%-2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-11.6%-4.7%
TTM-16.3%-11.7%-4.6%
YOY8.5%-11.4%+19.9%
3Y-1.2%-11.9%+10.7%
5Y-6.0%-12.0%+6.0%
10Y-3.6%-13.8%+10.2%
4.3.1.3. Return on Equity

Shows how efficient Formycon is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Formycon to theΒ Biotechnology industry mean.
  • -27.2% Return on Equity means Formycon generated €-0.27Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Formycon AG:

  • The MRQ is -27.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -27.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.2%TTM-27.2%0.0%
TTM-27.2%YOY15.1%-42.3%
TTM-27.2%5Y-6.9%-20.3%
5Y-6.9%10Y-4.1%-2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.2%-13.5%-13.7%
TTM-27.2%-15.0%-12.2%
YOY15.1%-14.5%+29.6%
3Y-0.7%-16.9%+16.2%
5Y-6.9%-17.7%+10.8%
10Y-4.1%-19.9%+15.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Formycon AG.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Formycon is operatingΒ .

  • Measures how much profit Formycon makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Formycon to theΒ Biotechnology industry mean.
  • An Operating Margin of -205.5%Β means the company generated €-2.05 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Formycon AG:

  • The MRQ is -205.5%. The company is operating very inefficient. -2
  • The TTM is -205.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-205.5%TTM-205.5%0.0%
TTM-205.5%YOY101.9%-307.4%
TTM-205.5%5Y-9.0%-196.5%
5Y-9.0%10Y-5.7%-3.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-205.5%-232.5%+27.0%
TTM-205.5%-250.3%+44.8%
YOY101.9%-208.4%+310.3%
3Y4.4%-221.7%+226.1%
5Y-9.0%-344.1%+335.1%
10Y-5.7%-470.4%+464.7%
4.3.2.2. Operating Ratio

Measures how efficient Formycon is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are €1.34 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Formycon AG:

  • The MRQ is 1.338. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.338. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.338TTM1.3380.000
TTM1.338YOY1.005+0.333
TTM1.3385Y1.261+0.077
5Y1.26110Y1.144+0.117
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3382.108-0.770
TTM1.3382.680-1.342
YOY1.0053.080-2.075
3Y1.2533.621-2.368
5Y1.2614.734-3.473
10Y1.1446.546-5.402
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Formycon AG.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Formycon is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.80Β means the company has €2.80 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Formycon AG:

  • The MRQ is 2.804. The company is able to pay all its short-term debts. +1
  • The TTM is 2.804. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.804TTM2.8040.000
TTM2.804YOY0.969+1.835
TTM2.8045Y3.616-0.812
5Y3.61610Y6.611-2.995
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8043.616-0.812
TTM2.8043.826-1.022
YOY0.9694.141-3.172
3Y1.4584.661-3.203
5Y3.6165.756-2.140
10Y6.6116.149+0.462
4.4.3.2. Quick Ratio

Measures if Formycon is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Formycon to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.14Β means the company can pay off €2.14 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Formycon AG:

  • The MRQ is 2.141. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.141. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.141TTM2.1410.000
TTM2.141YOY0.799+1.342
TTM2.1415Y3.740-1.599
5Y3.74010Y8.859-5.119
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1412.799-0.658
TTM2.1413.143-1.002
YOY0.7993.794-2.995
3Y2.2294.307-2.078
5Y3.7405.707-1.967
10Y8.8596.457+2.402
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Formycon AG.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of FormyconΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Formycon to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.40Β means that Formycon assets areΒ financed with 40.2% credit (debt) and the remaining percentage (100% - 40.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Formycon AG:

  • The MRQ is 0.402. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.402. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.402TTM0.4020.000
TTM0.402YOY0.435-0.034
TTM0.4025Y0.346+0.056
5Y0.34610Y0.242+0.104
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4020.327+0.075
TTM0.4020.348+0.054
YOY0.4350.327+0.108
3Y0.4730.340+0.133
5Y0.3460.349-0.003
10Y0.2420.379-0.137
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Formycon is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Formycon to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 67.1% means that company has €0.67 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Formycon AG:

  • The MRQ is 0.671. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.671. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.671TTM0.6710.000
TTM0.671YOY0.771-0.100
TTM0.6715Y0.642+0.028
5Y0.64210Y0.402+0.241
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6710.379+0.292
TTM0.6710.435+0.236
YOY0.7710.412+0.359
3Y0.9450.448+0.497
5Y0.6420.460+0.182
10Y0.4020.509-0.107
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Formycon generates.

  • Above 15 is considered overpriced butΒ always compareΒ Formycon to theΒ Biotechnology industry mean.
  • A PE ratio of -7.46 means the investor is paying €-7.46Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Formycon AG:

  • The EOD is -4.090. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.464. Based on the earnings, the company is expensive. -2
  • The TTM is -7.464. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.090MRQ-7.464+3.373
MRQ-7.464TTM-7.4640.000
TTM-7.464YOY13.144-20.608
TTM-7.4645Y-37.439+29.975
5Y-37.43910Y-11.032-26.408
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.090-2.303-1.787
MRQ-7.464-2.062-5.402
TTM-7.464-2.541-4.923
YOY13.144-3.741+16.885
3Y16.045-3.754+19.799
5Y-37.439-6.136-31.303
10Y-11.032-6.686-4.346
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Formycon AG:

  • The EOD is -9.669. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.644. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.644. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.669MRQ-17.644+7.975
MRQ-17.644TTM-17.6440.000
TTM-17.644YOY-32.561+14.917
TTM-17.6445Y-63.077+45.433
5Y-63.07710Y-343.925+280.848
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.669-3.178-6.491
MRQ-17.644-2.700-14.944
TTM-17.644-3.619-14.025
YOY-32.561-4.357-28.204
3Y-27.867-5.065-22.802
5Y-63.077-8.478-54.599
10Y-343.925-9.275-334.650
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Formycon is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 2.03 means the investor is paying €2.03Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Formycon AG:

  • The EOD is 1.113. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.031. Based on the equity, the company is underpriced. +1
  • The TTM is 2.031. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.113MRQ2.031-0.918
MRQ2.031TTM2.0310.000
TTM2.031YOY1.982+0.049
TTM2.0315Y8.141-6.110
5Y8.14110Y12.590-4.449
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1131.963-0.850
MRQ2.0311.848+0.183
TTM2.0312.119-0.088
YOY1.9822.469-0.487
3Y2.7662.526+0.240
5Y8.1413.664+4.477
10Y12.5904.351+8.239
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets771,715
Total Liabilities309,872
Total Stockholder Equity461,843
 As reported
Total Liabilities 309,872
Total Stockholder Equity+ 461,843
Total Assets = 771,715

Assets

Total Assets771,715
Total Current Assets95,025
Long-term Assets676,691
Total Current Assets
Cash And Cash Equivalents 41,834
Short-term Investments 6
Net Receivables 30,709
Inventory 262
Other Current Assets 22,214
Total Current Assets  (as reported)95,025
Total Current Assets  (calculated)95,025
+/-0
Long-term Assets
Property Plant Equipment 14,570
Intangible Assets 444,117
Long-term Assets Other 66,140
Long-term Assets  (as reported)676,691
Long-term Assets  (calculated)524,827
+/- 151,864

Liabilities & Shareholders' Equity

Total Current Liabilities33,893
Long-term Liabilities275,979
Total Stockholder Equity461,843
Total Current Liabilities
Short-term Debt 1,496
Accounts payable 17,437
Other Current Liabilities 12,932
Total Current Liabilities  (as reported)33,893
Total Current Liabilities  (calculated)31,865
+/- 2,028
Long-term Liabilities
Capital Lease Obligations 10,593
Long-term Liabilities Other 164,726
Long-term Liabilities  (as reported)275,979
Long-term Liabilities  (calculated)175,319
+/- 100,660
Total Stockholder Equity
Common Stock17,664
Retained Earnings -51,843
Other Stockholders Equity 496,022
Total Stockholder Equity (as reported)461,843
Total Stockholder Equity (calculated)461,843
+/-0
Other
Capital Stock17,664
Cash and Short Term Investments 41,840
Common Stock Shares Outstanding 17,492
Liabilities and Stockholders Equity 771,715
Net Debt -31,241
Net Invested Capital 461,843
Net Working Capital 61,132
Property Plant and Equipment Gross 24,140
Short Long Term Debt Total 10,593



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
> Total Assets 
701
4,280
5,594
7,640
15,445
16,906
27,147
25,186
30,828
39,624
53,555
75,598
70,715
853,697
890,362
771,715
771,715890,362853,69770,71575,59853,55539,62430,82825,18627,14716,90615,4457,6405,5944,280701
   > Total Current Assets 
648
4,014
2,159
445
10,902
12,849
23,307
20,672
26,631
18,746
28,060
50,507
37,942
30,502
67,147
95,025
95,02567,14730,50237,94250,50728,06018,74626,63120,67223,30712,84910,9024452,1594,014648
       Cash And Cash Equivalents 
7
1,371
3
213
899
289
622
2,995
4,505
7,336
22,116
42,009
25,029
9,820
27,035
41,834
41,83427,0359,82025,02942,00922,1167,3364,5052,99562228989921331,3717
       Short-term Investments 
0
2,500
1,800
2
9,506
8,935
19,675
10,972
10,974
4,972
238
238
150
164,526
6
6
66164,5261502382384,97210,97410,97219,6758,9359,50621,8002,5000
       Net Receivables 
0
104
250
26
0
3,252
2,757
5,209
10,519
5,168
4,920
-138
11,938
15,475
28,304
30,709
30,70928,30415,47511,938-1384,9205,16810,5195,2092,7573,2520262501040
       Other Current Assets 
641
143
56
124
222
27
121
864
139
54
379
7,403
1,382
9,272
11,335
22,214
22,21411,3359,2721,3827,403379541398641212722212456143641
   > Long-term Assets 
53
265
435
5,562
4,543
4,057
3,687
4,039
4,114
20,213
25,495
25,092
32,773
823,195
823,215
676,691
676,691823,215823,19532,77325,09225,49520,2134,1144,0393,6874,0574,5435,56243526553
       Property Plant Equipment 
9
146
300
3,745
2,987
2,689
2,553
3,049
3,255
3,473
3,701
3,501
8,431
11,516
12,327
14,570
14,57012,32711,5168,4313,5013,7013,4733,2553,0492,5532,6892,9873,7453001469
       Goodwill 
0
0
0
1,537
1,379
1,222
1,064
906
749
591
433
276
118
44,534
44,534
0
044,53444,5341182764335917499061,0641,2221,3791,537000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
15,973
0
0
0
0
0
0
00000015,973000000000
       Intangible Assets 
44
49
40
256
177
120
70
83
109
176
632
499
727
532,973
508,403
444,117
444,117508,403532,9737274996321761098370120177256404944
       Other Assets 
0
0
3,000
1,632
0
27
153
475
83
665
0
0
689
1
0
-1
-10168900665834751532701,6323,00000
> Total Liabilities 
61
209
457
3,380
3,194
3,265
2,276
4,295
5,284
6,384
5,345
7,563
14,824
497,117
387,611
309,872
309,872387,611497,11714,8247,5635,3456,3845,2844,2952,2763,2653,1943,38045720961
   > Total Current Liabilities 
48
127
0
3,105
2,493
3,265
1,343
2,613
3,439
3,846
2,765
5,019
10,418
50,666
69,306
33,893
33,89369,30650,66610,4185,0192,7653,8463,4392,6131,3433,2652,4933,105012748
       Short-term Debt 
0
2,500
1,800
2
9,506
8,962
19,675
10,972
1
4,972
238
0
877
21,715
21,671
1,496
1,49621,67121,71587702384,972110,97219,6758,9629,50621,8002,5000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
1
0
0
0
0
20,790
20,485
0
020,48520,7900000100000000
       Accounts payable 
10
53
0
3,109
2,493
2,271
649
2,309
1,767
2,731
2,212
4,484
7,606
11,318
16,319
17,437
17,43716,31911,3187,6064,4842,2122,7311,7672,3096492,2712,4933,10905310
       Other Current Liabilities 
38
74
0
-4
205
994
694
-219
901
382
391
369
2,812
17,417
31,251
12,932
12,93231,25117,4172,812369391382901-219694994205-407438
   > Long-term Liabilities 
13
83
457
275
701
1,525
933
720
1,279
3,058
2,580
2,545
4,406
446,451
318,305
275,979
275,979318,305446,4514,4062,5452,5803,0581,2797209331,5257012754578313
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
4,981
4,406
27,594
0
0
0027,5944,4064,98100000000000
       Other Liabilities 
0
0
0
0
496
530
933
1,682
1,845
2,538
727
398
372
0
0
0
0003723987272,5381,8451,6829335304960000
> Total Stockholder Equity
640
4,070
5,137
4,260
12,251
13,111
24,871
20,891
25,544
33,240
48,211
68,035
55,891
356,580
502,751
461,843
461,843502,751356,58055,89168,03548,21133,24025,54420,89124,87113,11112,2514,2605,1374,070640
   Common Stock
30
4,239
4,576
5,082
8,627
8,627
9,080
9,100
9,344
9,423
10,000
11,000
11,065
15,129
16,053
17,664
17,66416,05315,12911,06511,00010,0009,4239,3449,1009,0808,6278,6275,0824,5764,23930
   Retained Earnings 
-485
-1,494
-2,784
-5,179
-14,623
-13,763
-13,186
-17,252
-18,833
-11,735
-14,028
-19,954
-37,959
-1,968
73,827
-51,843
-51,84373,827-1,968-37,959-19,954-14,028-11,735-18,833-17,252-13,186-13,763-14,623-5,179-2,784-1,494-485
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
1,095
1,325
3,345
6,060
0
18,248
28,977
29,044
35,033
35,552
52,239
76,989
82,785
343,419
412,871
496,022
496,022412,871343,41982,78576,98952,23935,55235,03329,04428,97718,24806,0603,3451,3251,095



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue69,674
Cost of Revenue-54,840
Gross Profit14,83414,834
 
Operating Income (+$)
Gross Profit14,834
Operating Expense-38,377
Operating Income-23,543-23,543
 
Operating Expense (+$)
Research Development16,503
Selling General Administrative20,085
Selling And Marketing Expenses1,302
Operating Expense38,37737,890
 
Net Interest Income (+$)
Interest Income3,595
Interest Expense-1,107
Other Finance Cost-0
Net Interest Income2,488
 
Pretax Income (+$)
Operating Income-23,543
Net Interest Income2,488
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-144,25397,167
EBIT - interestExpense = -144,271
-144,254
-124,565
Interest Expense1,107
Earnings Before Interest and Taxes (EBIT)-143,164-143,146
Earnings Before Interest and Taxes (EBITDA)-4,099
 
After tax Income (+$)
Income Before Tax-144,253
Tax Provision--18,582
Net Income From Continuing Ops-125,671-125,671
Net Income-125,672
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses93,217
Total Other Income/Expenses Net-120,710-2,488
 

Technical Analysis of Formycon
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Formycon. The general trend of Formycon is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Formycon's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Formycon Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Formycon AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 30.05 < 30.70 < 37.65.

The bearish price targets are: 25.70 > 24.90 > 21.75.

Know someone who trades $FYB? Share this with them.πŸ‘‡

Formycon AG Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Formycon AG. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Formycon AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Formycon AG. The current macd is 1.05880713.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Formycon price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Formycon. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Formycon price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Formycon AG Daily Moving Average Convergence/Divergence (MACD) ChartFormycon AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Formycon AG. The current adx is 33.15.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Formycon shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Formycon AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Formycon AG. The current sar is 26.36.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Formycon AG Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Formycon AG. The current rsi is 60.54. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Formycon AG Daily Relative Strength Index (RSI) ChartFormycon AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Formycon AG. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Formycon price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Formycon AG Daily Stochastic Oscillator ChartFormycon AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Formycon AG. The current cci is 74.12.

Formycon AG Daily Commodity Channel Index (CCI) ChartFormycon AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Formycon AG. The current cmo is 20.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Formycon AG Daily Chande Momentum Oscillator (CMO) ChartFormycon AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Formycon AG. The current willr is -32.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Formycon is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Formycon AG Daily Williams %R ChartFormycon AG Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Formycon AG.

Formycon AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Formycon AG. The current atr is 1.18611424.

Formycon AG Daily Average True Range (ATR) ChartFormycon AG Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Formycon AG. The current obv is -863,562.

Formycon AG Daily On-Balance Volume (OBV) ChartFormycon AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Formycon AG. The current mfi is 58.56.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Formycon AG Daily Money Flow Index (MFI) ChartFormycon AG Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Formycon AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Formycon AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Formycon AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.538
Ma 20Greater thanMa 5027.815
Ma 50Greater thanMa 10025.261
Ma 100Greater thanMa 20026.105
OpenGreater thanClose28.950
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Formycon with someone you think should read this too:
  • Are you bullish or bearish on Formycon? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Formycon? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Formycon AG

I send you an email if I find something interesting about Formycon AG.


Comments

How you think about this?

Leave a comment

Stay informed about Formycon AG.

Receive notifications about Formycon AG in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.